Immune thrombocytopenia: A review of upfront treatment strategies.

Abstract excerpt

Immune thrombocytopenia (ITP), resulting from antibody-mediated platelet destruction combined with impaired platelet production, is a rare cause of thrombocytopenia in both children and adults. The decision to treat newly diagnosed patients is based on several factors, including the desire to increase platelet count to prevent bleeding, induce remission, and improve health-related quality of life (HRQoL). At...

Topics

Join the communities discussing this publication.

• Disease Management
• Genetic Variation
• Prognosis
• Purpura, Thrombocytopenic, Idiopathic